Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. CILOXADEX (ciprofloxacine (chlorhydrate de)/ dexaméthasone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

CILOXADEX (ciprofloxacine (chlorhydrate de)/ dexaméthasone)

Medicine - Posted on Feb 17 2023
Active substance (DCI)
  • ciprofloxacine (chlorhydrate de)
  • dexaméthasone
history (3)
  • 2/1/23

    CILOXADEX (ciprofloxacine/dexaméthasone) - Antibiotique et corticoïde

    Avis défavorable à l’arrêt du remboursement en vue d’une commercialisation en non remboursable. L’essentiel Avis défavorable...
    icône flèche
  • 3/7/18

    CILOXADEX (ciprofloxacin, dexamethasone), anti-infective and corticosteroid

    Low clinical interest for cases of otorrhoea after grommet insertion CILOXADEX has been granted a marketing authorisation fo...
    icône flèche
  • 5/29/13

    CILOXADEX 3 mg/mL (ciprofloxacine + dexaméthasone en solution auriculaire), fluoroquinolone et corticoïde

    Pas d’avantage clinique démontré dans l’otite externe aiguë et l’otorrhée sur aérateur trans-tympanique CILOXADEX 3mg/ml, so...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • S02CA06
Manufacturer
MEDIPHA SANTE
Presentation

CILOXADEX 3 mg/1 mg par ml, suspension pour instillation auriculaire (code CIS : 68601502) 
1 flacon(s) compte-gouttes polyéthylène basse densité (PEBD) de 5 ml (CIP : 34009 224 397 1 6)

All our publications
    Bacterial infections Drug therapy Ear diseases Infectious diseases - miscellaneous Paediatrics Protheses and implants

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNrNmN9v2jAQx9/5K1Dek0Ap/TEFqo21G1KrMVq0aS+VSS7FzLXTs03D/vo5hG5plWitqdW9ICV27s6+u4+/ODrJb1l7BSip4AOvG3S8NvBYJJTfDLzZ1Zl/5J0MW9GSrEhl2mHQCbp7XjtmRMqBV4wGcyBcBt8vzj+C+R7QG7bakZgvIVaP5mlFWfCZyMUFyYo57WglaNK+BbUQycDLtNq8bUdSoYlieC/wp8xIDFG4fVMdXV7vV99HYWHsGVa1BDwn/KbWKHArm7FGBK5GRMGNwHVDvD0r21ROQQqNMUyIWkxQrGgCSa2LlDAJVk7S++QScMVAFU5qjYfL+FZaGSdLkk/hblwf9HszOlK58jt+97C/1+10Do6P9o/7Vq6wslX1WTCLCLMMk+u946Ner3cYAg9jykROEsj9mGYo0uIpphz8eMEELtYJmsT6Cfih+clJ4Z1IwcEynxOBijBHmaRy9LgYHflBuPtnxSRUZoysg6XMbLeKYLHdgAYZ7hZSrOAKDcSY2bMn9rlmLHxh1LMtYhxFXBBsJDRXDaQ5m9puxEhwBXlzRu3gqPJtLVKQr2f215MG/DMw0XNGY1sMGlBpkGo2HTdT8K0B8oFImKE7gnyjPBH38vXJVK0ER9FnG7jWGjVJ6xZZO+j2+9aN98OkreEkO9UoMggNs6jcBUVjnopdIWQqud7UQx2/aQlvNJiICYMGFeZbMszU7oNodNYd7jqvHKg1+un0yrakvmrA9eXmsdY0TQbVYrBjvIuDw9RwY+wv74gSDE4kusZ64CyUyuS7MDSd4ktidihI8b84QCrnvLs/FE7ERCmuSgg7Cn1enq7Pz6htY/5Lauwqn7ffb2V6rQ+FGnbIQ8lwZ6Qdn74+vP9qZ2dhTx6Rxp2bjc4ligruSkvpeb2Q2vW4MKnlZ2j48CVNacP9TmNpRmF5tzRsRWFxrzRs/QYQ0TV4
PZtQ23AJj8ELDCnn